Results 71 to 80 of about 447,491 (216)

Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial

open access: yesJournal for ImmunoTherapy of Cancer
Background Intratumoral oncolytic herpes simplex virus 2-GM CSF (OH2) injection has shown safety and antitumor efficacy in patients with solid tumors.
Lu Zhang   +18 more
doaj   +1 more source

Reconstruction and Financial Remuneration Following Soft Tissue Sarcoma Surgery [PDF]

open access: bronze, 2013
S. Hassan   +4 more
openalex   +1 more source

A Deep Attention-Multiple Instance Learning Framework to Predict Survival of Soft-Tissue Sarcoma from Whole Slide Images

open access: green, 2023
Van-Linh Le   +7 more
openalex   +2 more sources

Impact of COVID-19 pandemic on bone and soft tissue sarcoma patients’ consultation and diagnosis

open access: yesScientific Reports
The coronavirus disease (COVID-19) pandemic negatively affected the diagnosis and treatment of several cancer types. However, this pandemic’s exact impact and extent on bone and soft tissue sarcomas need to be clarified.
Ryunosuke Oyama   +16 more
doaj   +1 more source

Alveolar Soft Part Sarcoma with Unusual Cardiac Metastasis: A Case Report and Review of the Literature

open access: yesCase Reports in Cardiology, 2017
Alveolar soft part sarcoma is a very uncommon soft tissue malignancy which accounts for
Abhinav Tiwari   +6 more
doaj   +1 more source

Supplementary figure FS2 from Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma

open access: gold, 2023
Rutulkumar Patel   +17 more
openalex   +1 more source

Low NT5DC2 expression predicts favorable prognosis and suppresses soft tissue sarcoma progression via ECM-receptor interaction pathway

open access: yesTranslational Oncology
Background: Soft tissue sarcoma, a malignant tumor arising from mesenchymal tissues with poor prognosis. 5′-Nucleotidase Domain Containing 2 (NT5DC2) is a novel oncogene, and the precise involvement of NT5DC2 in soft tissue sarcoma were still undefined ...
Zhen Huang   +7 more
doaj   +1 more source

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.

open access: yesThe Lancet Oncology, 2017
H. Tawbi   +23 more
semanticscholar   +1 more source

Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma

open access: yesNature Communications
Soft tissue sarcoma is a broad family of mesenchymal malignancies exhibiting remarkable histological diversity. We portray the proteomic landscape of 272 soft tissue sarcomas representing 12 major subtypes.
Shaoshuai Tang   +25 more
doaj   +1 more source

Diagnostic Accuracy of Fine Needle Aspiration Cytology in Soft Tissue Sarcomas

open access: yesJournal of Rawalpindi Medical College, 2018
Background: To study diagnostic validity of fine needle aspiration cytology in soft tissue sarcoma. Methods: In this descriptive study patients of all ages and both gender with obvious soft tissue swellings and patient in whom both FNAC followed by ...
Soffia Khursheed   +2 more
doaj  

Home - About - Disclaimer - Privacy